Wilbert van Duijnhoven

Statistics

Publications

Citations

565

H-Index

Active since

2010

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Wilbert van Duijnhoven is an author at Janssen (Belgium) specializing in infectious disease pharmacotherapy, influenza antiviral therapy, and pharmacy.

Publications per year

2010–2020

Publications

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 330 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

Robert W. Finberg, Riin Lanno, David Anderson et al. · The Journal of Infectious Diseases · 2018 · 132 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose–response relationship

F. Pühringer, Mae O. Gordon, Ignace Demeyer et al. · British Journal of Anaesthesia · 2010 · 71 citations

Medicine, Anesthesiology, Pharmacotherapy +9

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

Brian J. O’Neil, Michael G. Ison, Marie Charlotte Hallouin-Bernard et al. · The Journal of Infectious Diseases · 2020 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

1–4 of 4